• SYNLAB strengthens its commitment to care excellence in Italy by pioneering the installation of a photon-counting CT scanner at its Naples medical and research centre; this is one of the first systems of its kind available in Europe, offering the most advanced imaging technology today.
• The new scanner enhances patient comfort and supports healthcare professionals with, faster, safer and more accurate diagnostics.

SYNLAB, a leader in medical diagnostic services and specialty testing in Europe, has reinforced its commitment to care excellence in Italy by pioneering the installation of a photon-counting CT scanner at its medical and research centre in Naples. This investment reflects the Group’s strategy of delivering best-in-class care excellence across its network.

Photon-counting CT marks one of the most significant advances in radiology in over a decade, offering next-generation imaging capabilities that transform both clinical outcomes and patient experience. Unlike conventional CT systems, it directly detects individual X-ray photons, enabling ultra-high-resolution imaging with markedly reduced radiation exposure and faster scan times. Integrated with advanced artificial intelligence, the new photon-counting CT scanner leverages deep learning algorithms to further enhance image quality, accelerate reporting, and support more accurate diagnostics.

This breakthrough technology allows clinicians to visualise anatomical structures with microscopic precision, supporting earlier and more accurate diagnoses in cardiovascular, neurological and oncological care and is particularly effective for complex cases such as coronary disease, tumour staging, and high-resolution lung studies. Designed with patient comfort in mind, the new scanner facilitates more streamlined procedures while equipping healthcare professionals with sharper, more actionable insights for timely and accurate decision-making.

SYNLAB Italy has invested over €9 million in advanced imaging diagnostics in 2024 and 2025, delivering more than 300,000 procedures this year alone.

This latest investment adds to SYNLAB’s recent opening of the SYNLAB Manifattura Firenze Medical Centre in Florence and follows a series of strategic acquisitions in the country. Together, these developments demonstrate SYNLAB’s long-term commitment to Italy and its ambition to be the diagnostic partner of choice for both patients and healthcare professionals.

“Our focus is on creating environments where patients feel safe, supported and well cared for,” said Iris Faull, Chief Medical Officer at SYNLAB Group. “At the same time, we are equipping healthcare professionals across disciplines with the most advanced tools available to deliver precise, efficient and high-quality diagnostics.”

Installing the photon-counting CT scanner in Naples is a significant step forward in offering innovative diagnostic solutions tailored to the needs of patients and healthcare professionals alike.

– Ends –

For more information:

About SYNLAB

• SYNLAB Group is a leader in medical diagnostic services and specialty testing in Europe. The Group offers a full range of innovative and reliable medical diagnostics to patients, practising doctors, hospitals and clinics, governments, and corporates.
• Providing the leading level of service within the industry, SYNLAB is the partner of choice for routine and specialty diagnostics in human medicine. The Group continuously innovates medical diagnostic services for the benefit of patients and customers.
• SYNLAB operates in more than 20 countries across four continents and holds leading positions in most markets, regularly reinforcing the strength of its network through a proven acquisition strategy. More than 24,000 employees, including over 2,000 medical experts, contribute every day to the Group’s worldwide success.
• SYNLAB performed around 600 million laboratory tests and achieved revenues of €2.62 billion in 2024.
• More information can be found on www.synlab.com